Mark Bach

Dr. Bach is a pediatric endocrinologist with 30 years of clinical research and pharmaceutical development experience, including extensive global experience building and leading clinical teams that have successfully launched innovative pharmaceutical products into global markets. Dr. Bach is currently Chief Medical Officer at ShouTi. At his last position, Dr. Bach served as Senior Vice President of Endocrine Medical Sciences at Ascendis Pharma. Previously, Dr. Bach served as interim CEO and led a team to design and establish Accumulus Synergy, Inc., a cross-industry initiative to design and build a cloud-based platform to facilitate data exchange between pharmaceutical companies and health authorities. Prior to this, Dr. Bach was based in Asia, and served as Head of Asia Pacific Medical Sciences and Head of China R&D at Janssen Pharmaceutical Co.. Before that, he was Vice President of Research & Development and Scientific Affairs for Janssen Pharmaceutical KK in Japan. For 16 years, Dr. Bach held positions of increasing responsibility in Clinical Research at Merck & Co., Inc., ending his tenure there as Vice President of Clinical Research Operations Worldwide. Dr. Bach has lectured in national and international forums, has numerous publications and served on professional society advisory boards to advance the field of endocrinology and clinical research. Dr. Bach received an M.D. from Baylor College of Medicine, a Ph.D. in pathology from The University of Chicago, and a B.A. in chemistry from Carleton College.